Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Other Accumulated Expenses (2016 - 2025)

Utah Medical Products has reported Other Accumulated Expenses over the past 14 years, most recently at $1.7 million for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $1.7 million for Q4 2025, up 1409.01% from a year ago — trailing twelve months through Dec 2025 was $1.7 million (up 1409.01% YoY), and the annual figure for FY2025 was $1.7 million, up 1409.01%.
  • Other Accumulated Expenses for Q4 2025 was $1.7 million at Utah Medical Products, up from $111000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for UTMD hit a ceiling of $1.7 million in Q4 2025 and a floor of $111000.0 in Q4 2024.
  • Median Other Accumulated Expenses over the past 5 years was $257000.0 (2023), compared with a mean of $774800.0.
  • Biggest five-year swings in Other Accumulated Expenses: crashed 87.46% in 2022 and later skyrocketed 1409.01% in 2025.
  • Utah Medical Products' Other Accumulated Expenses stood at $1.6 million in 2021, then crashed by 87.46% to $204000.0 in 2022, then increased by 25.98% to $257000.0 in 2023, then plummeted by 56.81% to $111000.0 in 2024, then skyrocketed by 1409.01% to $1.7 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $1.7 million (Q4 2025), $111000.0 (Q4 2024), and $257000.0 (Q4 2023) per Business Quant data.